Find the latest Novavax, Inc. (NVAX) stock quote, history, news and other vital information to help you with your stock trading and investing. Novavax, Inc.
(NVAX) Stock Price, News, Quote & History - Yahoo Finance MSN: Novavax Stock Faces Retail Backlash As Shah Capital Warns Of Proxy Fight And Presses For A Sale Shah Capital increased its stake to about 8.3% and said the gap between Novavax’s scientific potential and its commercial results has become “striking.” The fund urged the board to form a committee to ... Novavax Stock Faces Retail Backlash As Shah Capital Warns Of Proxy Fight And Presses For A Sale Novavax is a biotech company with a proven technology, focused on developing our R&D assets and establishing partnerships to help protect health. Our Company Novavax is committed to developing life-saving innovations that reach billions around the world. Novavax is proudly headquartered in the USA with main offices in Gaithersburg, Maryland.
novavax stock message board, We conduct R&D and manufacturing for our Matrix-M adjuvant in Uppsala, Sweden. The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, [1] among others, is a subunit COVID-19 vaccine developed by Novavax and the Coalition for Epidemic Preparedness Innovations. The Novavax vaccine is one of three vaccines available in the U.S. for the prevention of COVID-19 and the only one that does not use the relatively new mRNA vaccine technology. Instead, it relies on a traditional virus-blocking technology that’s been used against other diseases.
novavax stock message board, In April 2025, Novavax was still in the process of obtaining full licensure for its COVID-19 vaccine, having submitted a Biologics License Application to the FDA, who requested Novavax complete an additional clinical trial.